Related Experiment Video

Updated: May 29, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses

Jennifer Altomonte1, Oliver Ebert

  • 1II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

Microbial Biotechnology
|September 20, 2011
PubMed

Insights

Oncolytic viruses are novel cancer treatments. Host immune responses are critical for their effectiveness, influencing both viral replication and anti-cancer immunity.

Area of Science:

  • Oncology
  • Immunology
  • Virology

Background:

  • Oncolytic viruses are emerging as promising anticancer agents.
  • Therapeutic strategies have historically focused on direct viral tumor lysis.
  • Emerging evidence highlights the crucial role of host immune responses in oncolytic virotherapy efficacy.

Purpose of the Study:

  • To review the dual role of the immune system in oncolytic virotherapy.
  • To discuss how immune responses can both limit and enhance therapeutic outcomes.
  • To explore strategies for modulating immune responses to improve oncolytic virus efficacy.

Main Methods:

  • Literature review of preclinical and clinical studies on oncolytic viruses.
  • Analysis of the interplay between oncolytic viruses and host immune system.
  • Synthesis of current knowledge on immune evasion and promotion strategies.

Main Results:

  • Immune responses can restrict oncolytic virus replication, potentially limiting efficacy.
  • Oncolytic viruses can elicit potent anti-tumour immune responses.
  • Immune system plays a critical role in the overall success of oncolytic virotherapy.

Conclusions:

  • Understanding and manipulating host immune responses is key to optimizing oncolytic virotherapy.
  • Strategies to enhance anti-tumour immunity while managing antiviral responses are needed.
  • Further research into immune system modulation will improve therapeutic potential.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...